Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypothalamic control of lipid metabolism.

Literature DB >> 2986421

Hypothalamic control of lipid metabolism.

Abstract

Obesity as a common disorder of lipid metabolism might be caused by defective hypothalamic control as demonstrated by ventromedial lesions or the effect of cholecystokinin application. The hypothalamic proopiomelanocorticotropin is the precursor of hormonal fragments affecting fat mobilisation, the endocrine pancreas and gastrointestinal functions.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1985 PMID： 2986421 DOI： 10.1007/bf01406332

Source DB: PubMed Journal: Acta Neurochir (Wien) ISSN： 0001-6268 Impact factor: 2.216

24 in total

1. Plasma insulin levels during imaginary food ingestion under hypnosis.

Authors: I D Goldfine; C Abraira; D Gruenewald; M S Goldstein
Journal: Proc Soc Exp Biol Med Date: 1970-01

2. Naloxone decreases food intake in obese humans.

Authors: R L Atkinson
Journal: J Clin Endocrinol Metab Date: 1982-07 Impact factor: 5.958

3. Peripheral insulin in response to the sight and smell of food.

Authors: L Sjöström; G Garellick; M Krotkiewski; A Luyckx
Journal: Metabolism Date: 1980-10 Impact factor: 8.694

4. beta-Lipotropin increases plasma insulin immunoreactivity.

Authors: P Schwandt; W O Richter; P Kerscher; P Bottermann
Journal: Life Sci Date: 1981-07-27 Impact factor: 5.037

5. Vagotomy for treatment of severe obesity.

Authors: J G Kral
Journal: Lancet Date: 1978-02-11 Impact factor: 79.321

6. Fall in plasma content of free fatty acids associated with sight of food.

Authors: S B Penick; H Prince; L E Hinkle
Journal: N Engl J Med Date: 1966-08-25 Impact factor: 91.245

7. The role of vagally-medicated hyperinsulinemia in hypothalamic obesity.

Authors: B M King; L A Frohman
Journal: Neurosci Biobehav Rev Date: 1982 Impact factor: 8.989

8. Evidence that the insulin secretagogue, beta-cell-tropin, is ACTH22-39.

Authors: A Beloff-Chain; J Morton; S Dunmore; G W Taylor; H R Morris
Journal: Nature Date: 1983-01-20 Impact factor: 49.962

9. C-terminal octapeptide of cholecystokinin decreases food intake in man.

Authors: H R Kissileff; F X Pi-Sunyer; J Thornton; G P Smith
Journal: Am J Clin Nutr Date: 1981-02 Impact factor: 7.045

10. beta-Endorphin stimulates the secretion of insulin and glucagon in humans.

Authors: R L Reid; S S Yen
Journal: J Clin Endocrinol Metab Date: 1981-03 Impact factor: 5.958

2 in total

Review 1. Leveraging melanocortin pathways to treat glomerular diseases.

Authors: Rujun Gong
Journal: Adv Chronic Kidney Dis Date: 2014-03 Impact factor: 3.620

2. Synthetic ACTH for Treatment of Glomerular Diseases: A Case Series.

Authors: Arenn Jauhal; Bhanu Prasad; Mathieu Rousseau-Gagnon; Gabriel Ouellet; Michelle A Hladunewich
Journal: Can J Kidney Health Dis Date: 2022-01-05

2 in total